Viewing StudyNCT00426452



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00426452
Status: COMPLETED
Last Update Posted: 2009-11-19
First Post: 2007-01-23

Brief Title: A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Healthy
Keywords:
Name View
Vascular endothelial growth factor receptor VEGF-R tyrosine kinase inhibitor View
Vatalinib View
Proton-pump inhibitors View
Omeprazole View
Healthy Postmenopausal Female Volunteers View